<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00012909</url>
  </required_header>
  <id_info>
    <org_study_id>PCC 98-039</org_study_id>
    <nct_id>NCT00012909</nct_id>
  </id_info>
  <brief_title>Development and Evaluation of a Hormone Replacement Therapy Decision-Aid</brief_title>
  <official_title>Development and Evaluation of a Hormone Replacement Therapy Decision-Aid</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>US Department of Veterans Affairs</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The decision regarding the use of post-menopausal estrogen hormone replacement therapy (HT)&#xD;
      is complex because patients must balance the short and long-term risks and benefits.&#xD;
      Information from new and important clinical trials must also be considered. The purpose of&#xD;
      this research is to develop and evaluate the efficacy of a HT CD-ROM decision-aid in&#xD;
      improving the decision making process for women considering the use of estrogen HT.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:&#xD;
&#xD;
      The decision regarding the use of post-menopausal estrogen hormone replacement therapy (HT)&#xD;
      is complex because patients must balance the short and long-term risks and benefits.&#xD;
      Information from new and important clinical trials must also be considered. The purpose of&#xD;
      this research is to develop and evaluate the efficacy of a HT CD-ROM decision-aid in&#xD;
      improving the decision making process for women considering the use of estrogen HT.&#xD;
&#xD;
      Objectives:&#xD;
&#xD;
      The objectives of the study are to: 1) develop a model of the decision-making process for&#xD;
      postmenopausal women considering hormone (HT), based on Multi-Attribute Utility Theory&#xD;
      (MAUT); 2) produce an interactive CD-ROM decision-aid for HT; 3) evaluate the effect of the&#xD;
      interactive CD-ROM decision-aid on patient satisfaction with decision (SWD) and knowledge&#xD;
      about menopause and HT; and 4) test the effect of the interactive CD-ROM decision-aid on&#xD;
      womenï¿½s decisions regarding use of HT.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      Phase I (completed) used structured interviews and surveys in the development of a decision&#xD;
      model for HT. In phase II, an interactive CD-ROM decision-aid was developed and a randomized&#xD;
      controlled trial (RCT) of its effect on decision processes was conducted. Postmenopausal&#xD;
      women, aged 45-74 were recruited from the primary care clinics of the four participating&#xD;
      Veterans Affairs hospitals: Milwaukee, Madison, Chicago-Hines, and Chicago-Westside. The&#xD;
      primary hypothesis was that women who use the CD-ROM decision-aid would demonstrate increased&#xD;
      satisfaction with their decision regarding hormone replacement therapy use compared to women&#xD;
      receiving the control intervention.&#xD;
&#xD;
      Status:&#xD;
&#xD;
      Enrollment and follow-up assessments have been completed. The study is in the analysis phase.&#xD;
      The study was presented to the VA HSR&amp;D Combined Monitoring Board on February 5, 2003 and the&#xD;
      committee voted unanimously to recommend continuation of the trial. The study has had one&#xD;
      publication and several scientific abstract presentations.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <completion_date type="Actual">March 2004</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Menopause</condition>
  <condition>Hormone Replacement Therapy</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Hormone Replacement Therapy Decision-Aid</intervention_name>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - postmenopausal as defined by: Amenorrhea for 12 months or FSH greater than or equal to 25&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  unable to speak English&#xD;
&#xD;
          -  are assessed not to have capacity for making medical decisions for their own care&#xD;
&#xD;
          -  had alcohol or drug abuse issues in past 6 months before baseline visit&#xD;
&#xD;
          -  personal history of breast cancer, active liver disease, active vascular thrombosis,&#xD;
             and/or active unexplained vaginal bleeding&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marilyn M. Schapira, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clement J. Zablocki VA Medical Center, Milwaukee, WI</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arneda Van White, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Edward Hines Jr. VA Hospital, Hines, IL</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Edward Hines Jr. VA Hospital, Hines, IL</name>
      <address>
        <city>Hines</city>
        <state>Illinois</state>
        <zip>60141-5000</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clement J. Zablocki VA Medical Center, Milwaukee, WI</name>
      <address>
        <city>Milwaukee</city>
        <state>Pennsylvania</state>
        <zip>53295-1000</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William S. Middleton Memorial Veterans Hospital, Madison, WI</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Schapira MM, Gilligan MA, McAuliffe TL, Nattinger AB. Menopausal hormone therapy decisions: insights from a multi-attribute model. Patient Educ Couns. 2004 Jan;52(1):89-95.</citation>
    <PMID>14729295</PMID>
  </results_reference>
  <verification_date>November 2007</verification_date>
  <study_first_submitted>March 14, 2001</study_first_submitted>
  <study_first_submitted_qc>March 15, 2001</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2001</study_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

